Surge in patients increases Raffles Medical’s 3Q14 revenue by 11.1%

As healthcare insurance services also spike.

4Q is traditionally Raffles Medical Group’s strongest quarter, but this time 3Q is also bringing in solid statistics.

According to a report by OCBC Investment Research, Raffles Medical Group (RMG) reported a double-digit YoY growth in both its topline and bottomline for its 3Q14 results.

Revenue was up 11.1% YoY to S$94.5m due to a higher patient load, addition of specialist consultants and increased provision of healthcare insurance services; while PATMI jumped by 11.3% to S$15.4m.

For 9M14, revenue increased 8.6% to S$274.6m, and constituted 72.1% of our FY14 forecast. PATMI rose 9.2% to S$45.6m, or 67.1% of OCBC’s full-year projection.